British American Tobacco (BMTA) AI Stock Analysis

British American Tobacco

(Frankfurt:BMTA)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

New Category GrowthRapid growth in New Categories, especially Modern Oral, is building a larger recurring-consumables business alongside combustibles. Rising consumer adoption, category profitability, and scale can support portfolio diversification and sustain growth as nicotine preferences evolve over the next several quarters.

Negative Factors

Meaningful LeverageMeaningful debt relative to equity reduces financial flexibility and leaves the company more exposed to financing costs and refinancing requirements. Although debt has declined from earlier levels, leverage can constrain capital allocation and limit resilience if operating conditions weaken.

British American Tobacco (BMTA) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 132.23B
Dividend Yield: 5.35%
Average Volume (3M): 255
Price to Earnings (P/E): 15.7
Beta (1Y): 0.02
Revenue Growth: -2.63%
EPS Growth: 104.26%
Country: Germany
Employees: 47,797
Sector: Consumer Defensive
Sector Strength: 62
Industry: Tobacco

British American Tobacco Business Overview & Revenue Model

Company Description

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the United States, Europe, Latin America, Canada, the Asia-Pacific, the Middle East, Central Asia, Caucasus, and Africa. The company offers vapour products; heated...

British American Tobacco Earnings Call Summary

Earnings Call Date:Jul 29, 2026(Q2-2026)|% Change Since:0.63%|Next Earnings Date:Feb 10, 2027

Earnings Call SentimentPositive

The call presented multiple clear progress points: strong New Category growth (notably Modern Oral), solid US multi-category performance, margin expansion, improved cash generation, and a defined Fit2Win savings trajectory. These positives are balanced by material near-term challenges: declines in Heated Products and Vapour revenues in some regions, APMEA profit pressure, combustible volume declines and market-specific shocks (e.g., Brazil excise), ongoing regulatory and illicit market issues, and sizable one-off/non-cash charges. Management reiterated confidence in recovery and a pathway to return to the midterm algorithm while emphasizing targeted investments for sustainable growth.

Positive Updates

Smokeless Revenue Progress and Consumer Adds

Smokeless now represents 19.8% of group revenue (up 160 basis points year-on-year). The business added 4.1 million smokeless consumers over the last 12 months, taking the total to 35 million, driven mainly by Modern Oral and the Velo brand.

Negative Updates

Heated Products Revenue Declines and Competitive Pressures

Heated product (glo) revenue declined nearly 12% overall; APMEA heated product revenue declined 13%. Performance impacted by inventory movements and heightened competitive intensity in the value segment (notably Italy, Poland).

Company Guidance

Guidance: management expects a H2‑weighted recovery with adjusted profit from operations accelerating in H2 and full‑year adjusted EPS now expected toward the middle of the 5–8% range, while revenue and operating profit are expected at the lower end of the algorithm after absorbing c.1% transactional FX headwind; key H2 drivers are mid‑teens New Category revenue growth (after H1 New Categories +18% and Modern Oral +66%), an AME acceleration and APMEA sequential recovery, plus positive phasing of Fit2Win benefits. Financial targets include net finance cost of c.£1.65bn, an underlying tax rate of 24–25%, reaching target leverage of 2.0–2.5x by year‑end, a £1.3bn 2026 share buyback alongside the progressive dividend, and a commitment to deliver >£50bn free cash flow by 2030; Fit2Win is now expected to deliver £700m annualized savings by 2028 (£500m by 2027) with total one‑off costs ~£950m (£840m adjusting).

British American Tobacco Risk Analysis

British American Tobacco disclosed 1 risk factors in its most recent earnings report. British American Tobacco reported the most risks in the "Legal & Regulatory" category.

Legal & Regulatory - Litigation, compliance, new legislation, and taxation risks

Latest Risks Added

1 New Risk

1.2.3Supplemental Indenture No. 1, dated as of 28 September 2018, among British American Tobacco p.l.c. and certain of its subsidiaries as guarantors, and Wilmington Trust, National Association, as Trustee.4Q4, 2025

British American Tobacco Peers Comparison

Overall Rating

UnderperformOutperform

Sector (62)

Financial Indicators

DE:BMTA against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
RLX	69Neutral	$1.97B	13.37	6.20%	6.83%	59.23%	39.66%
PM	68Neutral	$325.43B	30.48	-119.68%	2.88%	7.91%	24.06%
MO	65Neutral	$129.80B	16.12	-279.72%	5.50%	2.41%	-7.63%
TPB	65Neutral	$1.35B	28.28	11.93%	0.47%	20.10%	-3.19%
Sector *	62Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
UVV	49Neutral	$1.03B	54.53	1.33%	7.96%	-3.04%	-81.53%

* Consumer Defensive Sector Average

Performance Comparison

DE:BMTA and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:BMTA	British American Tobacco	55.00	12.42	29.16%
MO	Altria	78.03	24.95	47.00%
PM	Philip Morris International	208.79	69.13	49.50%
UVV	Universal Corporation	41.44	-6.05	-12.75%
TPB	Turning Point Brands Inc	67.31	-25.97	-27.84%
RLX	Rlx Technology, Inc.	1.61	-0.69	-29.97%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

British American Tobacco AI Stock Analysis